Obermatt
See Similar Stocks →

Sanofi India

NSI:SANOFI · INE058A01010
PharmaceuticalsSmall

360° View

56
Price/Sales55
Price/Earnings38
Price/Book10
Dividend Yield1
Revenue Growth15
Profit Growth32
Capital Growth23
TSR 52w8
Leverage83
Liquidity98
Refinancing39
Combined42
Analyst Opinions41
Pro Holdings51
Opinion Changes50
Market Pulse27

Profile

CountryFrance
IndustryPharmaceuticals
SizeSmall
TypePublic Company
ExchangeBSE
Founded1956
Employees446
Websitesanofi.com/en/india
ISININE058A01010
Last UpdateApr 2, 2026
Index & Theme
Pain ManagementCardiovascularCentral Nervous SystemOncologyVaccinesDiabetesNeurologyAllergyHealth Care

Description

Sanofi India Limited engages in the research, development, manufacturing, and distribution of medicines. Business Segments The company operates through segments: pharmaceutical products, vaccines, consumer healthcare, and specialty products. Pharm…

Analysis

Sanofi India's 360° View rank of 56 places it above its peer average — better than 56% of its true peers.

It's lagging on growth (5) and expensive versus peers (19). On safety it is very well financed (77), and the market shows muted sentiment (31). Taken together, its Combined rank of 42 reads as below its peer average.

360° rank · history

1007550250
56
2023202420252026

All-time high

79

Jan 2023

All-time low

43

Jan 2024

Average rank

59

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
55
36
29
39
Price/Earnings
38
42
50
50
Price/Book
10
10
14
43
Dividend Yield
1
67
76
82
Value (overall)
19
35
43
55

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Sanofi India with its peers
Bayer
GER:BAYN
15
CountryGermany
IndustryPharmaceuticals
SizeXX-Large
Full Stock Analysis →
Avadel Pharmaceuticals
NMQ:AVDL
70
CountryIreland
IndustryPharmaceuticals
SizeSmall
Full Stock Analysis →
Sandoz
SWX:SDZ
18
CountrySwitzerland
IndustryPharmaceuticals
SizeX-Large
Full Stock Analysis →
GSK
LSE:GSK
72
CountryUK
IndustryPharmaceuticals
SizeXX-Large
Full Stock Analysis →
Cohance Lifesciences
NSI:COHANCE
37
CountryCyprus
IndustryPharmaceuticals
SizeSmall
Full Stock Analysis →
Sanofi
PAR:SAN
91
CountryFrance
IndustryPharmaceuticals
SizeLarge
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →